Systematic Screening for Chlamydia trachomatis: Estimating Cost-Effectiveness Using Dynamic Modeling and Dutch Data
- 1 January 2006
- journal article
- Published by Elsevier in Value in Health
- Vol. 9 (1) , 1-11
- https://doi.org/10.1111/j.1524-4733.2006.00075.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimensSexually Transmitted Infections, 2001
- Cost-Effectiveness of Partner Pharmacotherapy in Screening Women for Asymptomatic Infection with Chlamydia TrachomatisValue in Health, 2001
- Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The NetherlandsPharmacoEconomics, 2001
- Cost-Effectiveness of Screening Programs for Chlamydia trachomatisSexually Transmitted Diseases, 2000
- Analysing the effectiveness of Chlamydia screeningJournal of the Operational Research Society, 2000
- Chlamydia trachomatis in Adolescents and AdultsPharmacoEconomics, 1998
- AzithromycinPharmacoEconomics, 1997
- Performance and Cost-Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in WomenSexually Transmitted Diseases, 1997
- Prevention of Pelvic Inflammatory Disease by Screening for Cervical Chlamydial InfectionNew England Journal of Medicine, 1996
- Pelvic Inflammatory Disease and FertilitySexually Transmitted Diseases, 1992